Figure S1 - CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis

Proteomic analysis of CSF samples from patients with prodromal schizophrenia, and depression patients. (A) and (B) PLS-DA scores plots showing a degree of separation of prodromal schizophrenia patients (?) from depression patients (?) as determined by the SELDI CSF spectra. The key changing proteomic peaks are from secretogranin II (529-566) and two transthyretin isoforms. (0.99 MB DOC)